The Viral Hepatitis Prevention Board and the European Liver Patients Association jointly organized a meeting (Lucca, Italy, 13-14 March 2008) to review the role and impact of patients' organizations and advocacy groups in Europe and the USA on the prevention and control of viral hepatitis. The national and international groups described a wide variety of organizational structures, means of funding, services and activities. Participants reported numerous obstacles and difficulties, ranging from limited funding, weak governmental support and the lack of a high-profile lobby to residual prejudice against people with viral hepatitis and cultural barriers. The groups' experiences formed an impressive list of strengths and achievements, including international and national campaigns, networking, building of excellent relations with the media, support from and respect of professional bodies, greater respect of patients' human rights, improved access to counselling and treatment, and influence on national and international policies. The meeting highlighted opportunities, for example, to complete programmes of immunization against hepatitis B, to convince governments of the economic value of public health interventions, and raise awareness of the value of a healthy liver.

Prevention and control of viral hepatitis : the role and impact of patient and advocacy groups in and outside Europe / S. Badur, P. Bonanni, M. Colinet, V. Delpire, E. Engelen, D. FitzSimons, I. Gardini, D. Goldberg, C. Gore, N. Guérin, J. Hallauer, S. Hasurdjiev, G. Hendrickx, L. Hessel, G. Ionescu, W. Jilg, A. Kautz, T. King Thiel, D. Lavanchy, M. Lipucci di Paola, R. Tato Marinho, S. Matthews, L. Mosina, N. Piorkowski, T. Reic, F. Roudot-Thoraval, C. Shapiro, D. Shouval, I. Sikorska, Z. Simonovic, S. So, P. Van Damme, A. Van der Pooten, P. Van Leeuwen, F. Vanden Berghe, A. Vorsters, J. Ward, D. Wexler, S. Wiersma, A. Zanetti. - In: VACCINE. - ISSN 0264-410X. - 26:45(2008), pp. 5669-5674. ((Intervento presentato al convegno Prevention and control of viral hepatitis : the role and impact of patient and advocacy groups in and outside Europe held : 13–14 March tenutosi a Lucca nel 2008.

Prevention and control of viral hepatitis : the role and impact of patient and advocacy groups in and outside Europe

A. Zanetti
Ultimo
2008

Abstract

The Viral Hepatitis Prevention Board and the European Liver Patients Association jointly organized a meeting (Lucca, Italy, 13-14 March 2008) to review the role and impact of patients' organizations and advocacy groups in Europe and the USA on the prevention and control of viral hepatitis. The national and international groups described a wide variety of organizational structures, means of funding, services and activities. Participants reported numerous obstacles and difficulties, ranging from limited funding, weak governmental support and the lack of a high-profile lobby to residual prejudice against people with viral hepatitis and cultural barriers. The groups' experiences formed an impressive list of strengths and achievements, including international and national campaigns, networking, building of excellent relations with the media, support from and respect of professional bodies, greater respect of patients' human rights, improved access to counselling and treatment, and influence on national and international policies. The meeting highlighted opportunities, for example, to complete programmes of immunization against hepatitis B, to convince governments of the economic value of public health interventions, and raise awareness of the value of a healthy liver.
advocacy; patient groups; patients; prevention; viral hepatitis
Settore MED/42 - Igiene Generale e Applicata
Article (author)
File in questo prodotto:
File Dimensione Formato  
Vaccine_ConfReport_2008.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 124.71 kB
Formato Adobe PDF
124.71 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/181385
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 2
social impact